Astrana Health Competitors
| ASTH Stock | 24.02 0.21 0.88% |
Astrana Health and Lifestance Health Correlation Overview
Moderate diversification
The correlation between Astrana Health and Lifestance Health is 0.21, which Macroaxis classifies as Moderate diversification for the selected horizon. This chart helps evaluate whether adding Lifestance Health genuinely reduces risk relative to holding Astrana Health alone.
Moving together with Astrana Stock
Moving against Astrana Stock
The concept of mean reversion suggests that Astrana Health's price will eventually return toward its long-run average. Positions sized too aggressively against the trend can suffer sustained losses before reversion occurs in Astrana Health. The mean reversion framework for Astrana Health is built on the premise that markets are not perfectly efficient.
Astrana Health Competition Correlation Matrix
Studying peer correlation around Astrana Health gives investors a cleaner read on how much independent price behavior still exists across the competitive set. Used correctly, correlation analysis helps separate broad industry exposure from company-specific behavior before additional capital is allocated across the peer group.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
Evaluating Astrana Stock requires separating price momentum from underlying operating strength versus competitors. Risk-adjusted metrics help compare Astrana Health's efficiency and downside exposure against peers on a like-for-like basis. These indicators are quantitative in nature and help investors evaluate volatility and risk-adjusted expected returns across different positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SEM | 0.83 | 0.14 | 0.12 | 0.68 | 1.16 | 2.08 | 8.88 | |||
| MD | 1.54 | 0.03 | 0.00 | -0.02 | 0.00 | 2.87 | 15.10 | |||
| NHC | 1.55 | 0.25 | 0.14 | 0.39 | 1.71 | 4.32 | 9.97 | |||
| AVAH | 2.08 | -0.41 | 0.00 | -0.61 | 0.00 | 3.11 | 18.26 | |||
| ACHC | 3.36 | 0.91 | 0.27 | -13.08 | 2.93 | 7.14 | 33.41 | |||
| USPH | 1.42 | -0.01 | 0.00 | -0.06 | 0.00 | 3.19 | 10.34 | |||
| MNKD | 3.05 | -1.25 | 0.00 | -3.38 | 0.00 | 4.09 | 42.20 | |||
| OMCL | 2.17 | -0.29 | 0.00 | -0.23 | 0.00 | 3.97 | 22.92 | |||
| HCSG | 1.80 | 0.13 | 0.05 | 0.07 | 2.40 | 3.07 | 20.02 | |||
| LFST | 1.50 | 0.03 | 0.00 | -0.04 | 0.00 | 3.26 | 10.51 |
Peer Comparison: Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Astrana Health financial statement analysis. It represents the amount of money remaining after all of Astrana Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Compare Astrana Health and related stocks such as Select Medical Holdings, Mednax Inc, and National HealthCare Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SEM | -27.9 M | 107.8 M | 148.2 M | 114.4 M | 120.6 M | 130.7 M | 115.4 M | 177.2 M | 137.8 M | 148.4 M | 259 M | 402.2 M | 159 M | 243.5 M | 214 M | 146.2 M | 152 M |
| MD | 5.4 M | 218 M | 240.9 M | 280.5 M | 317.3 M | 336.3 M | 324.9 M | 320.4 M | 268.6 M | -1.5 B | -796.5 M | 131 M | 66.3 M | -60.4 M | -99.1 M | 165.4 M | 173.7 M |
| NHC | 17.7 M | 65 M | 59.3 M | 64.6 M | 53.4 M | 53.1 M | 50.5 M | 56.2 M | 59 M | 68.2 M | 41.9 M | 138.6 M | 22.4 M | 66.8 M | 101.9 M | 120 M | 126 M |
| AVAH | -47.1 M | -47.1 M | -47.1 M | -47.1 M | -47.1 M | -47.1 M | -47.1 M | -47.1 M | -47.1 M | -76.5 M | -57 M | -117 M | -662 M | -134.5 M | -10.9 M | 225 M | 236.3 M |
| ACHC | 6.2 M | -34.9 M | 20.4 M | 42.6 M | 83 M | 119.5 M | 6.1 M | 199.8 M | -175.8 M | 108.9 M | -672.1 M | 190.6 M | 273.1 M | -21.7 M | 255.6 M | -1.1 B | -1 B |
| USPH | -200 K | 21 M | 17.9 M | 12.7 M | 19.8 M | 22.3 M | 20.6 M | 22.3 M | 10.1 M | 28.1 M | 30.6 M | 27.8 M | 28.3 M | 14.7 M | 26.5 M | 15.1 M | 13 M |
| MNKD | -24.7 M | -160.8 M | -169.4 M | -191.5 M | -198.4 M | -368.4 M | 125.7 M | -117.3 M | -87 M | -51.9 M | -57.2 M | -80.9 M | -87.4 M | -11.9 M | 27.6 M | 5.9 M | 6.2 M |
| OMCL | -20.8 M | 10.4 M | 16.2 M | 24 M | 30.5 M | 30.8 M | 603 K | 20.6 M | 37.7 M | 61.3 M | 32.2 M | 77.8 M | 5.6 M | -20.4 M | 12.5 M | 2.1 M | 1.9 M |
| HCSG | 1.5 M | 38.2 M | 44.2 M | 47.1 M | 21.9 M | 58 M | 77.4 M | 88.2 M | 83.5 M | 64.6 M | 98.7 M | 48.5 M | 34.2 M | 38.4 M | 39.5 M | 59.1 M | 29.9 M |
| LFST | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | -38.1 M | -307.2 M | -215.6 M | -186.3 M | -57.4 M | 9.7 M | 10.1 M |
Astrana Health Competitive Analysis
Placing Astrana Health next to Select Medical, Mednax, and National HealthCare puts raw numbers into competitive context. A 1.36 B valuation paired with 3.18 B in revenue sets the baseline. Profitability stands at a 0.71% net margin with return on equity reaching 4.49%. Net profitability gives Select Medical an edge at 2.68% versus Astrana Health at 0.71%. Mednax leads with 20.28% return on equity versus 4.49% for Astrana Health. Revenue tilts toward Astrana Health at 3.18 B compared with 1.51 B.| Better Than Average | Worse Than Peers | View Performance Chart |
Astrana Health Competition Peer Performance Charts
How to Analyze Astrana Health Against Peers
Astrana Health's peer analysis compares Astrana Health with related companies to put valuation, quality, and risk metrics in context. This helps determine whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:- Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
- Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
- Check valuation dispersion: Review whether Astrana Health trades at a premium or discount versus peers and why.
- Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
- Document the thesis: Record where Astrana Health leads or lags and what catalysts could close or widen the gap.
Peer Comparison Metrics & Methodology
Astrana Health trades at a lower forward P/E than peers despite similar earnings growth, which may reflect differences in perceived risk or growth durability. Competition analysis adds context to price action by grounding it in relative fundamentals. For peer comparison, Astrana Health has a market cap of 1.36 B, profit margin of 0.71%.
Data shown for Astrana Health is aggregated from periodic company reporting and market reference feeds and normalized across reporting formats. Analyst projections are included when active coverage applies. Source publication timing can introduce delays.